Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barron Signs Off With Notes On GSK Culture Change, Tease On RSV Vaccine Results

Transformation Not Yet Complete, Says Departing R&D Chief

Executive Summary

Hal Barron is leaving just as GSK’s M&A firepower grows following the Haleon spin-out, but sounded a confident note about its potential blockbuster RSV vaccine candidate.

You may also be interested in...



GSK’s New Research Chief Begins Leadership With Expanded Genomics/AI Alliance

GSK’s new chief scientific officer Tony Wood is building on the precision medicine approach by partnering with Tempus to accelerate cancer drug trials and improve the firm’s R&D productivity.

Consumer Spin-Off Finally Achieved, GSK Will Weigh More M&A

GSK is entering a new era, and CEO Emma Walmsley looks likely to use new finances for more targeted M&A.

GSK Registers A Win For Older People RSV Vaccine – But Awaited Data Will Be Crucial

GSK has declared success for its RSV vaccine and will begin regulatory talks immediately – but the final efficacy level, as yet unrevealed, could be decisive in a competitive market.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC146786

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel